Yutaka Niihara, Chairman and CEO, 10% Owner at Emmaus Life Sciences, Inc. (EMMA), bought 7,700 shares at $1.48 ($11K) on 2021-12-27, disclosed to the SEC on 2021-12-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.48 | 5,000 | $7K | 64.8% |
| 2 | $1.50 | 1,500 | $2K | 19.7% |
| 3 | $1.48 | 1,200 | $2K | 15.5% |
| Total | $1.48 avg | 7,700 | $11K | 100% |
| Filing → |
| EMMA | BUY | 2022-10-31 | $19K | — | Filing → |
| EMMA | BUY | 2022-10-24 | $11K | — | Filing → |
| EMMA | BUY | 2022-10-19 | $9K | — | Filing → |